Agio stock price today
Agios Pharmaceuticals (NASDAQ: AGIO) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and Today's Range. 37.01 Q1 2020 Agios Pharmaceuticals Inc Earnings Release Apr 30, 2020 BRIEF-Agios prices offering of 7.09 mln shares at $67 per share. 7 Dec 2019 tell us much about whether insiders might find today's price attractive. Agios Pharmaceuticals is not the only stock insiders are buying. 7 Nov 2019 (Nasdaq: AGIO) today announced that it has priced an underwritten public offering of 8,250,000 shares of common stock at a price to the public of
View live AGIOS PHARMACEUTICALS INC chart to track its stock's price action. a Next-Generation PKR Activator Agios Pharmaceuticals, Inc. (AGIO) today
Stock analysis for Agios Pharmaceuticals Inc (AGIO:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Agios Pharmaceuticals Inc. Stock Price (AGIO) | Barron's View today's stock price, news and analysis for Agios Pharmaceuticals Inc. (AGIO). Barron's also provides information on historical stock ratings, target … Why Agios Pharmaceuticals Inc Stock Fell Sharply Today ...
7 Dec 2019 tell us much about whether insiders might find today's price attractive. Agios Pharmaceuticals is not the only stock insiders are buying.
AGIO Stock Price and Chart — NASDAQ:AGIO — TradingView View live AGIOS PHARMACEUTICALS INC chart to track its stock's price action. Find market predictions, AGIO financials and market news. AGIO:NASDAQ GS Stock Quote - Agios Pharmaceuticals Inc ...
Agio Paper & Industries Share Price : Live NSE/BSE Stock ...
Agios A Buy On Stock Price Retreat, Cholangiocarcinoma ...
In depth view into AGIO (Agios Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials.
AGIO (Common Stock). Price, 33.3, Change, +0.55. Volume, 856,629, % Change, +1.68%. Intraday High, 36.52, 52 Week High, 68.89. Intraday Low, 32.53, 52
Agios Pharmaceuticals, Inc. (AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products issued a positive opinion on the company’s application for orphan drug designation for its investigational medicine AGIO Stock Price Today - Agios Pharmaceuticals Inc Stock Quote Get your free Agios Pharmaceuticals Inc stock live and up-to-date data - AGIO Quote, charts, rates, analysis, news & forecasts. Enter Now!